Parallel Advisors »

Neumora Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $498 279 1.79

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Cvb Finl Corp Stock (CVBF)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Vanguard Large Cap Etf (VV)
Avantis International Equity Etf Etf (AVDE)
Ishares Core Msci Eafe Etf Etf (IEFA)

View all positions for Parallel Advisors

Top funds holding Neumora Therapeutics

Softbank Group Corp
Siren
Vanguard Group
MIC Capital Management UK
Point72 Asset Management
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
BlackRock
Millennium Management
Johnson & Johnson
Renaissance Technologies
Ikarian Capital
Jane Street

View all funds holding Neumora Therapeutics